IL18 and myeloid sarcoma: Furthermore, in future studies, it will be important to determine whether this is a characteristic of other pro-inflammatory cytokines (IL-12, IL-18, macrophage migration inhibitor factor) involved in MS pathogenesis [48,49,50,51].